IVMED-85 eye drops for childhood myopia
Part of Eyes & vision clinical trials.
This study tests an experimental eye drop called IVMED-85 to see if it can slow down or stop the progression of nearsightedness (myopia) in children and teenagers. If it works, it might help keep their vision from getting worse as they grow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 5 and 16 years old (some age groups start later).
- Your nearsightedness must be within a certain range, and your eyes must be otherwise healthy.
- You must not have had certain eye surgeries or treatments for myopia before.
- You must be able to attend study visits and follow the study plan.
- A parent or guardian must agree to the study, and you must agree too.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing the safety and comfort of new glasses with special lenses designed to slow down nearsightedness in children. It compares differences between the new lenses and regular lenses, and the child will wear them for a period of time to see how they feel and if there are any concerns.
This trial tests an eye drop called MR-61 to see if it can slow down worsening nearsightedness (myopia) in children and teens. The study aims to find a safe and easy way to keep their vision from getting worse.
This study tests an eye drop (QLM3004) to see if it can slow down the progression of nearsightedness (myopia) in children. It might be a good option if your child is between 6 and 12, has mild to moderate nearsightedness, and hasn't used other myopia treatments before.
This study tests a new eye drop medicine (T10430) to see if it can slow down how fast children's nearsightedness gets worse. The trial will measure whether the drops are safe and effective for kids ages 6–11.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This study tests a new type of eyeglass lenses (called Myoless2.0) designed to slow the progression of nearsightedness (myopia) in children. If your child is eligible, they would wear these special glasses to help reduce the risk of their prescription getting worse over time.
Hear when a new Myopia, Progressive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.